Biotechnology Innovation Organization (BIO) is proud to conclude the 2024 BIO International Convention in San Diego, held last week June 3-6, 2024. 1,400 exhibitors and more than 19,500 attendees from 70 countries came together for four full days of programming designed to propel the biotechnology industry forward. BIO 2024 also exceeded its prior record of partnering meetings with over 61,000 held this year. From patient advocacy to policy initiatives and next generation biotherapeutics, BIO 2024 showcased the innovative breakthroughs to help solve the world’s biggest problems.  “There was a great spirit of hope that resonated throughout the Convention halls this year. It was a hope and excitement based upon the convergence of the brightest minds in science, business, government, and patient advocacy all coming together with an extraordinary focus on healing, fueling, and feeding the world,” said John F. Crowley, President & CEO, BIO. “As Christopher Reeve once said, ‘biotechnology is just a great big word that means hope.’ It is that spirit that I continue to see in all corners of our industry around the globe as we advance policies and priorities that will propel the science forward and expand access for patients and people worldwide. It is my hope that every day, more and more people will enjoy the life changing benefits of what we do.”BIO 2024 featured an inspiring discussion about leadership from Four-Star Admiral, Retired U.S. Navy (SEAL), and the Former Chancellor of The University of Texas System, William McRaven. Award-winning actress and author, Viola Davis shared her powerful story about what it really means to be a loving and caring human being in the face of immense adversity in life with former CNN anchor Brooke Baldwin. FDA Commissioner Robert Califf, MD, spoke about regulatory innovations in the industry and highlighted specifically the importance of a resilient manufacturing supply chain that includes major efforts to redomicile key parts…